Table of Contents Author Guidelines Submit a Manuscript
Clinical Study

Refractive and biometric outcomes in patients with retinopathy of prematurity treated with intravitreal injection of Ranibizumab as compared with Bevacizumab — a clinical study of correction at three years of age

Received 7 November 2017; Accepted 14 January 2018

Academic Editor: Toshihide Kurihara